Skip to main content
. 2017 Apr 21;108(4):671–677. doi: 10.1111/cas.13182

Figure 3.

Figure 3

Kaplan−Meier curves for survival based on HER2 somatic mutations in HER2‐negative patients with primary breast cancer (n = 953). (a) Recurrence‐free survival. (b) Distant recurrence‐free survival. HER2, human epidermal growth factor receptor 2; mut, mutant; wt, wild‐type.